Tanaka Hiroshi, Kakizaki Hidehiro, Shibata Takashi, Ameda Kaname, Koyanagi Tomohiko
Department of Urology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
J Urol. 2003 Oct;170(4 Pt 1):1427-31. doi: 10.1097/01.ju.0000074713.69589.4a.
To determine the role of N-methyl-D-aspartate (NMDA) glutamatergic receptors in the development of functional bladder changes after partial urethral obstruction we investigated the effects of repeat injection of MK-801, a noncompetitive NMDA receptor antagonist, on the micturition reflex in conscious obstructed rats.
In 9 female Wistar rats 1.0 mg/kg MK-801 was injected intramuscularly once weekly just prior to the creation of partial urethral obstruction until 5 weeks after obstruction. Five to 7 days after the last injection of MK-801 conscious filling cystometry was performed and compared with that in 9 obstructed rats treated with vehicle (saline). Conscious filling cystometry was also compared in 9 and 7 sham operated rats treated with repeat injection of MK-801 and vehicle, respectively.
Partial urethral obstruction caused a significant increase in bladder weight. However, chronic MK-801 treatment did not affect bladder weight in obstructed or sham operated rats. In the obstructed/MK-801 vs the obstructed/vehicle group chronic treatment with MK-801 significantly increased bladder capacity (2.29 +/- 0.12 vs 1.73 +/- 0.16 ml, p <0.01) and voided volume (2.00 +/- 0.10 vs 1.56 +/- 0.17 ml, p <0.05) without changes in voiding efficiency (87.5% +/- 1.6% vs 87.8% +/- 1.7%) or micturition pressure (55.8 +/- 2.3 vs 56.4 +/- 3.0 cm water). Interestingly neither the frequency nor amplitude of premicturition contractions during filling was different in the groups. In sham operated rats chronic MK-801 treatment did not change bladder capacity, voided volume, voiding efficiency or micturition pressure significantly.
The results in the current study suggest that bladder outlet obstruction causes NMDA receptor mediated alterations in bladder afferent pathways in the rat.
为了确定N-甲基-D-天冬氨酸(NMDA)谷氨酸能受体在部分尿道梗阻后功能性膀胱变化发展中的作用,我们研究了重复注射非竞争性NMDA受体拮抗剂MK-801对清醒梗阻大鼠排尿反射的影响。
在9只雌性Wistar大鼠中,于每次部分尿道梗阻形成前每周一次肌肉注射1.0mg/kg MK-801,直至梗阻后5周。在最后一次注射MK-801后5至7天,进行清醒充盈膀胱测压,并与9只接受赋形剂(生理盐水)治疗的梗阻大鼠进行比较。还分别比较了9只和7只接受重复注射MK-801和赋形剂治疗的假手术大鼠的清醒充盈膀胱测压结果。
部分尿道梗阻导致膀胱重量显著增加。然而,慢性MK-801治疗对梗阻或假手术大鼠的膀胱重量没有影响。在梗阻/MK-801组与梗阻/赋形剂组中,MK-801慢性治疗显著增加了膀胱容量(2.29±0.12 vs 1.73±0.16ml,p<0.01)和排尿量(2.00±0.10 vs 1.56±0.17ml,p<0.05),而排尿效率(87.5%±1.6% vs 87.8%±1.7%)或排尿压力(55.8±2.3 vs 56.4±3.0cm水柱)没有变化。有趣的是,两组在充盈期间排尿前收缩的频率和幅度均无差异。在假手术大鼠中,慢性MK-801治疗对膀胱容量、排尿量、排尿效率或排尿压力没有显著改变。
本研究结果表明,膀胱出口梗阻会导致大鼠膀胱传入通路中NMDA受体介导的改变。